|
FY2025
12 months to Dec 31, 2025
|
FY2024
11 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Interest income from Trust Account | |||||
| Change in fair value of convertible promissory notes – related parties | |||||
| Depreciation, depletion, amortization and accretion | |||||
| Share based compensation expense | |||||
| Amortization of operating lease right-of-use asset | |||||
| Amortization of debt issuance costs | |||||
| Paid-in-kind interest | |||||
| Effect of amendment to the Senior Secured Term Loan | |||||
| Deferred tax expense (benefit) | |||||
| Change in fair value of warrant liabilities | |||||
| Materials, supplies and other assets | |||||
| Prepaid expenses | |||||
| Changes in current assets and current liabilities, net of effect of acquisition: | |||||
| Inventory | |||||
| Material and supplies | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Income taxes payable | |||||
| Due to related party | |||||
| Net cash used in operating activities | |||||
| Cash withdrawn from Trust Account to pay taxes | |||||
| Cash flows from investing activities: | |||||
| Payments for capital expenditures | |||||
| Cash consideration paid | |||||
| Net cash used in investing activities | |||||
| Proceeds from convertible promissory notes – related parties | |||||
| Proceeds from promissory notes - related party | |||||
| Cash flows from financing activities: | |||||
| Capital contribution from parent | |||||
| Offering proceeds | |||||
| Payment of equity issuance costs | |||||
| Cash received on warrant exercises, net | |||||
| Payment on Senior Secured Term Loan | |||||
| Payment of debt issuance costs | |||||
| Payment of non-convertible promissory notes—related parties | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents | |||||
| Net change in cash | |||||
| Net change in cash | |||||
| Cash, cash equivalents and restricted cash, beginning of the period | |||||
| Cash, cash equivalents and restricted cash, end of the period | |||||
| Conversion of Promissory Notes to Convertible Promissory Notes | |||||
| Remeasurement of Class A common stock subject to possible redemption | |||||
| Excise tax payable as a result of redemptions of Class A common stock | |||||
| Initial measurement of fair value of Convertible Promissory Notes | |||||
| Payment of cash taxes | |||||
| Senior Secured Term Loan, including paid-in-kind interest | |||||
| Supplies and materials | |||||
| Accrued liabilities | |||||
| Deferred tax liability | |||||
| Asset retirement obligations assumed | |||||
| Right of use assets obtained in exchange for operating lease liabilities | |||||
| Acquisition Of Transportation Assets | |||||
| Warrant liability removed upon exercise | |||||
| Change in capital expenditure accrual | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...